Treatment of Gout with H.P.C

. 1954 Oct 2;2(4891):782–786. doi: 10.1136/bmj.2.4891.782

PMCID: PMC2079130 PMID: 13199307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BLANCHARD K. C., HARVEY A. M., HOWARD J. E., KATTUS A., MARSHALL E. K., Jr, NEWMAN E. V., ZUBROD C. G. The effect of 3-hydroxy-2-phenylcinchoninic acid upon rheumatic fever. Bull Johns Hopkins Hosp. 1950 Jul;87(1):50–60. [PubMed] [Google Scholar]
EHRLICH M. E., BERKOWITZ S., CARP S. G., SOBLEN R., STEINBROCKER O. The effectiveness of hydroxy-phenyl cinchoninic acid in rheumatoid arthritis. N Y State J Med. 1952 Jan 15;52(2):227–230. [PubMed] [Google Scholar]
MARSHALL E. K., Jr, DEARBORN E. H. Certain aspects of the pharmacology of 3-hydroxy-2-phenylcinchoninic acid. Bull Johns Hopkins Hosp. 1950 Jul;87(1):36–49. [PubMed] [Google Scholar]
RENNIE J. B., MILNE J. A., SOMMERVILLE J. Trial of a cinchoninic acid derivative in some collagen diseases. Br Med J. 1951 Feb 24;1(4703):383–388. doi: 10.1136/bmj.1.4703.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
SIMSON J., BUNIM J. J. The anti-rheumatic effects of 3-hydroxy-2-phenylcinchoninic acid (HPC) in gout, rheumatic fever, and rheumatoid arthritis. Am J Med Sci. 1951 Nov;222(5):523–529. doi: 10.1097/00000441-195111000-00006. [DOI] [PubMed] [Google Scholar]